Ambrein
CAS 473-03-0
Ambrein (CAS 473-03-0) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 4.6 ug.mL-1 | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ambrein used for in pharmaceutical contexts?
Ambrein (CAS 473-03-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ambrein?
No adverse-event association or SIDER side-effect rows are rendered for Ambrein in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ambrein also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Ambrein.
What clinical phase is Ambrein in?
No phase 1-4 clinical development badge is rendered for Ambrein because the matched compound identifier rows do not contain a max-phase value.